J&J: Caplyta® (Lumateperone) Shows Significant And Rapid Improvement In Bipolar Mania In Pivotal Phase 3 Study

Caplyta Demonstrates Statistically Significant Rapid Reduction In Manic Symptoms At Week 3 Caplyta Well-Tolerated; Dry Mouth And Nausea Most Common Adverse Events